| |
| |
|
| Insider
Information: |
Dolsten Mikael |
| Relationship: |
Director |
| City: |
Madison |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
327,440 |
|
|
Indirect Shares
|
1,981 |
|
|
| Direct
Value |
$9,895,676 |
|
|
|
Indirect Value
|
$56,181 |
|
|
| Total
Shares |
329,421 |
|
|
| Total
Value |
$9,951,857 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -16.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pfizer Inc |
PFE |
President R&D |
2024-02-28 |
321,729 |
2024-02-28 |
1,981 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
5,711 |
2021-09-22 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFE |
Pfizer Inc |
President R&D |
• • – |
2016-02-24 |
4 |
D |
$29.67 |
$4,518,495 |
D/D |
(151,673) |
426,229 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-12-17 |
4 |
OE |
$30.17 |
$2,147,712 |
D/D |
71,187 |
351,637 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2022-11-07 |
4 |
OE |
$30.17 |
$2,627,260 |
D/D |
79,108 |
420,007 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2016-02-28 |
4 |
D |
$30.23 |
$288,666 |
D/D |
(9,549) |
435,210 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-03-01 |
4 |
OE |
$30.59 |
$3,328,057 |
D/D |
106,191 |
438,679 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2014-02-26 |
4 |
D |
$31.99 |
$921,056 |
D/D |
(28,792) |
351,445 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2017-02-23 |
4 |
D |
$32.49 |
$5,269,931 |
D/D |
(159,600) |
140,315 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2014-03-04 |
4 |
S |
$32.57 |
$1,165,929 |
D/D |
(35,789) |
344,571 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-28 |
4 |
D |
$33.42 |
$1,318,285 |
D/D |
(39,446) |
268,515 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2015-02-25 |
4 |
D |
$33.47 |
$3,782,211 |
D/D |
(111,104) |
414,209 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$798,435 |
D/D |
(23,841) |
137,727 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4 |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
156,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2021-02-25 |
4/A |
D |
$33.82 |
$956,125 |
D/D |
(28,271) |
161,568 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2017-02-27 |
4 |
S |
$34.25 |
$2,016,244 |
D/D |
(58,846) |
80,288 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2017-02-27 |
4 |
D |
$34.28 |
$1,130,589 |
D/D |
(32,981) |
132,479 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2015-03-05 |
4 |
S |
$34.40 |
$2,009,152 |
D/D |
(58,298) |
355,911 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-02-26 |
4 |
D |
$34.72 |
$1,312,138 |
D/D |
(37,792) |
307,961 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-02-28 |
4 |
D |
$35.70 |
$5,681,080 |
D/D |
(158,482) |
134,870 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-03-02 |
4 |
S |
$35.85 |
$501,398 |
D/D |
(13,986) |
120,884 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-02-24 |
4 |
D |
$35.98 |
$3,954,664 |
D/D |
(109,493) |
115,772 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2018-03-09 |
4 |
S |
$36.55 |
$2,550,394 |
D/D |
(69,699) |
51,185 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2020-05-18 |
4 |
S |
$37.75 |
$3,602,681 |
D/D |
(95,353) |
174,918 |
0 |
% |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2023-02-25 |
4 |
D |
$41.75 |
$1,548,007 |
D/D |
(37,078) |
354,145 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2023-02-22 |
4 |
D |
$42.38 |
$1,381,249 |
D/D |
(32,592) |
391,223 |
0 |
- |
|
| PFE |
Pfizer Inc |
President R&D |
• • – |
2019-02-27 |
4 |
D |
$42.93 |
$3,167,075 |
D/D |
(73,773) |
332,488 |
0 |
- |
|
61 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
